|
2007E-0010:
Patent Extension Application for Chantix (varenicline), U.S. Patent No. 6,410,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed Date
|
| Submitter Code
|
| Submitter
|
| FR Date
|
| FR Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| APP1
|
| 01/05/2007
|
| 01/05/2007
|
| Drug Industry
|
| Pfizer, Inc.
|
|
|
|
|
|
|
| Table of Contents
|
|
|
|
|
| Signature:
|
| A. David Joran
|
|
|
|
|
| LET1
|
| 01/05/2007
|
| 01/05/2007
|
| Federal Government
|
| U.S. Patent and Trademark Office to FDA/CDER (HFD-7)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Mary C. Till
|
|
|
| LET2
|
| 01/26/2007
|
| 01/26/2007
|
| Federal Government
|
| FDA/CDER to the U.S. Patent and Trademark Office
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
|
|
Top | Page last updated:
March 8, 2007
|
